Filter Results:
(3,393)
Show Results For
- All HBS Web
(3,393)
- People (9)
- News (719)
- Research (2,177)
- Events (36)
- Multimedia (27)
- Faculty Publications (1,282)
Show Results For
- All HBS Web
(3,393)
- People (9)
- News (719)
- Research (2,177)
- Events (36)
- Multimedia (27)
- Faculty Publications (1,282)
- Research Summary
Overview
My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
- Research Summary
Overview
My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
- 01 Jun 2023
- News
Research Brief: The Best Medicine
the clinical approval process. In a survey experiment, the researchers found that 72 percent of doctors had been asked by their patients whether a new drug would “work in people like me.” Black patients and the doctors who treat them put less faith in trial evidence... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
1998. “But this grant is significant because it facilitates the sharing of plasma samples, collected from test subjects over time, with academic researchers.” The collaboration is a first for an international, late-stage trial and could... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
Moderna could create a vaccine for clinical testing in just 60 days. That was three times faster than any vaccine candidate had ever been produced. Fauci didn't believe him. An idea emerged to test Bancel’s... View Details
- Research Summary
Research Thrust
By: Rakesh Khurana
I am trained in organizational sociology and my main areas of interest lie in macro-organizational theory and the dynamics of executive labor markets. To date, my research has focused on two themes. The first revolves around understanding the forces that govern the... View Details
- January 17, 2022
- Article
Reducing Racial Disparities in Cancer Outcomes
By: Kathy Giusti and Richard G. Hamermesh
A disproportionate number of Black patients die from cancer in the United States. A key to addressing this problem is enrolling more Black patients in clinical trials. A strategy consisting of these three parts can help accomplish this goal: 1) centralize information... View Details
Giusti, Kathy, and Richard G. Hamermesh. "Reducing Racial Disparities in Cancer Outcomes." Harvard Business Review (website) (January 17, 2022).
- 08 Mar 2018
- Cold Call Podcast
Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?
Keywords: Health
- September 2008
- Background Note
Background on the Technology of Molecular Diagnostics
By: Regina E. Herzlinger and Jason Sanders
To be used as background reading for the "EXACT Sciences Corp.: Commercializing a Diagnostic Test" and "Diagnostic Genomics" cases, HBS nos. 308-090 and 309-040. View Details
Keywords: Health Testing and Trials; Technology; Biotechnology Industry; Medical Devices and Supplies Industry
Herzlinger, Regina E., and Jason Sanders. "Background on the Technology of Molecular Diagnostics." Harvard Business School Background Note 309-050, September 2008.
- 03 Jun 2020
- Research & Ideas
Who Guarantees Your Workplace Is Safe for Return?
50-60 percent recommended to minimize viral transmission. Sensors: Air quality and other measurable conditions. While it’s not currently possible to test directly for coronaviruses in the air, other measures like particulate counts,... View Details
- Article
Quantifying the Use of Connected Digital Products in Clinical Research
By: Caroline Marra, Jacqueline L. Chen, Andrea Coravos and Ariel D. Stern
Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g.,... View Details
Keywords: Connected Digital Products; Clinical Trials; Health Testing and Trials; Information Technology; Research
Marra, Caroline, Jacqueline L. Chen, Andrea Coravos, and Ariel D. Stern. "Quantifying the Use of Connected Digital Products in Clinical Research." Art. 50. npj Digital Medicine 3 (2020).
- 15 Jun 2004
- Conference Presentation
What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study
By: William B. Simpson, Frances J. Hayes, Andre B. Araujo and John B. McKinlay
Keywords: Measurement and Metrics; Health Testing and Trials; Age Characteristics; Gender Characteristics; Massachusetts
Simpson, William B., Frances J. Hayes, Andre B. Araujo, and John B. McKinlay. "What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study." Paper presented at the Enocrine Society Annual Meeting, New Orleans, LA, June 15, 2004.
- 28 Jan 2016
- News
Harvard Business School Launches Precision Trials Challenge
- 25 Apr 2014
- News
Bringing a new funding model to the life sciences industry
Andrew Farquharson (MBA 1999) wants to change the landscape for biomedical financing. The cofounder of VentureHealth, an online funding platform based in Silicon Valley, Farquharson leverages deals with investors who want access to biomedical startups. "If we can... View Details
- 31 Jul 2018
- Working Paper Summaries
How Does Product Liability Risk Affect Innovation? Evidence from Medical Implants
Keywords: by Alberto Galasso and Hong Luo
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses. View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Biotechnology Industry; Medical Devices and Supplies Industry; Asia; North America; Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- 1996
- Chapter
The Determinants of Research Productivity in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- October 2019
- Article
Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations
By: Derek C. Angus, Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, Marc J. M. Bonten, Mary Brophy, Christopher Butler, Timothy F. Cloughesy, Lennie P. G. Derde, Laura J. Esserman, Ryan Ferguson, Louis Fiore, Sarah C. Gaffey, J. Michael Gaziano, Kathy Giusti, Herman Goossens, Stephane Heritier, Bradley Hyman, Michael Krams, Kay Larholt, Lisa M. LaVange, Philip Lavori, Andrew W. Lo, Alexander J. London, Victoria Manax, Colin McArthur, Genevieve O’Neill, Giovanni Parmigiani, Jane Perlmutter, Elizabeth A. Petzold, Craig Ritchie, Kathryn M. Rowan, Christopher W. Seymour, Nathan I. Shapiro, Diane M. Simeone, Bradley Smith, Bradley Spellberg, Ariel Dora Stern, Lorenzo Trippa, Mark Trusheim, Kert Viele, Patrick Y. Wen and Janet Woodcock
Researchers, clinicians, policymakers, and patients are increasingly interested in questions about therapeutic interventions that are difficult or costly to answer with traditional, free-standing, parallel-group randomized controlled trials (RCTs). Examples include... View Details
Angus, Derek C., Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, Marc J. M. Bonten, Mary Brophy, Christopher Butler, Timothy F. Cloughesy, Lennie P. G. Derde, Laura J. Esserman, Ryan Ferguson, Louis Fiore, Sarah C. Gaffey, J. Michael Gaziano, Kathy Giusti, Herman Goossens, Stephane Heritier, Bradley Hyman, Michael Krams, Kay Larholt, Lisa M. LaVange, Philip Lavori, Andrew W. Lo, Alexander J. London, Victoria Manax, Colin McArthur, Genevieve O’Neill, Giovanni Parmigiani, Jane Perlmutter, Elizabeth A. Petzold, Craig Ritchie, Kathryn M. Rowan, Christopher W. Seymour, Nathan I. Shapiro, Diane M. Simeone, Bradley Smith, Bradley Spellberg, Ariel Dora Stern, Lorenzo Trippa, Mark Trusheim, Kert Viele, Patrick Y. Wen, and Janet Woodcock. "Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations." Nature Reviews: Drug Discovery 18, no. 10 (October 2019): 797–807.